Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Beyond weight and glucose, longterm outcomes, including cardiovascular events, are increasingly part of the evidence base
Novo Nordisk also offers a manufacturers savings card program
It typically starts at the lowest dosage, which is gradually increased as the patient adjusts to the medication and tolerates its potential side effects
Semaglutide reduces body weight by around 14% on average, while tirzepatide in clinical trials has shown up to 20% weight loss on average
US$ 23.07
US$ 21.89
US$ 22.60
US$ 28.65
